Company Monitoring Page for Janssen

latest headlines for company on cafepharma

Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar
First Word Pharma
Wed, 09/20/17 - 11:03 am
Tags:
Pfizer, JNJ, Janssen, Remicade, biosimilars, Inflectra
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Drug Channels
Wed, 09/20/17 - 09:05 am
Tags:
drug pricing, reimbursement, Remicade, biosimilars, Janssen, Inflectra, Pfizer, Renflexis, Merck
States Push Ahead With Investigation Into Opioid Painkillers
FOX Business
Tue, 09/19/17 - 10:41 pm
Tags:
opioids, opioid crisis, Endo International, Janssen, Allergan, Teva Pharmaceutical, Purdue Pharma
J&J inks $879M vaccine deal with Bavarian Nordic
BioPharma Dive
Fri, 07/28/17 - 11:29 am
Tags:
JNJ, vaccines, Bavarian Nordic, Janssen, hepatitis B
J&J touts first-in-human data for HIV vaccine
Drug Delivery Business News
Tue, 07/25/17 - 12:00 am
Tags:
JNJ, HIV, vaccines, Janssen
Drug Companies Lose Challenge To Alliance Of Private Lawyers And State Officials
Forbes
Thu, 07/13/17 - 09:10 am
Tags:
New Hampshire, Actavis, Endo Pharmaceuticals, Janssen, Purdue Pharma, Teva Pharmaceutical
Janssen gets EU nod for continuous manufacturing
BioPharma Dive
Fri, 06/30/17 - 09:45 am
Tags:
Janssen, Europe, drug manufacturing, Prezista, HIV
Ohio attorney general sues 5 pharma companies over their role in the opioid epidemic
CNBC
Wed, 05/31/17 - 10:54 pm
Tags:
Ohio, opioid crisis, opioids, opioid abuse, JNJ, Janssen, Teva Pharmaceutical, Purdue Pharma, Allergan, Endo Health Solutions
High Court Won’t Hear Dispute Challenging FDA Over J&J Drug
Bloomberg
Thu, 05/18/17 - 10:01 pm
Tags:
FDA, JNJ, Risperdal, Janssen
FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug Label
RAPS.org
Tue, 05/16/17 - 10:48 pm
Tags:
FDA, Janssen, type 2 diabetes, warnings, Invokana, Invokamet
J&J looks for the inside story with new online psoriasis campaign
Fierce Pharma
Tue, 03/28/17 - 10:54 am
Tags:
JNJ, psoriasis, Janssen, drug marketing
Biotech Renova takes over Janssen's rights to heart failure candidate stresscopin
Fierce Biotech
Tue, 02/7/17 - 10:34 am
Tags:
Renova Therapeutics, gene therapy, heart failure, Janssen, stresscopin
FDA to withdraw approval of Lannett's generic ADHD drug
Bizjournals.com
Thu, 10/20/16 - 09:30 am
Tags:
FDA, Lannett, generics, ADHD, Concerta, JNJ, Janssen
Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug
Market Realist
Mon, 09/26/16 - 09:58 am
Tags:
JNJ, FDA, type 2 diabetes, diabetes, Invokamet XR, Janssen
GlaxoSmithKline gambles against Gilead with risky bet on two-drug HIV combos
Fierce Pharma
Wed, 09/7/16 - 09:37 am
Tags:
GSK, Gilead Sciences, HIV, Tivicay, Edurant, Janssen, ViiV
GSK enters $230 million licensing deal with Janssen
BioPharma Dive
Thu, 07/28/16 - 01:46 pm
Tags:
GSK, Janssen, asthma
J&J's Janssen hit with $70 mln verdict in Risperdal trial
Yahoo/Reuters
Sat, 07/2/16 - 12:41 pm
Tags:
JNJ, Janssen, Risperdal, antipsychotics
FDA warns of kidney risks for diabetes drugs from Janssen, AstraZeneca
BioPharma Dive
Tue, 06/14/16 - 07:27 pm
Tags:
FDA, diabetes, Janssen, JNJ, AstraZeneca, Farxiga, Invokana
J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, too
Fierce Pharma
Mon, 06/13/16 - 07:10 pm
Tags:
JNJ, Invokana, type 1 diabetes, Janssen
Janssen's multiple myeloma drug passes muster in Europe
BioPharma Dive
Tue, 05/24/16 - 11:42 pm
Tags:
Janssen, Multiple Myeloma, Europe, JNJ, Darazalex

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.